PDLIM7 and nasopharyngeal carcinoma: Targeting LMP1 or LMP2A by transfection of EBV-CRISPR-Cas9 plasmids in another type of EBV-infected NPC cells (Cantonese nasopharyngeal epithelial cells or CNE-2 cells) inhibited EBV replication [64].